🔎 Trials Near Me

Gara Jalqabaatti › Lipoid Nephrosis › New York

Qorannoo klinikaalii Lipoid Nephrosis New York keessatti

Qorannoo 6 Lipoid Nephrosis f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  • Columbia University Irving Medical Center- Site Number : 8400001, New York
  • The Children's Hospital at Montefiore- Site Number : 8400027, The Bronx
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 16 hanga 75 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06500702

NEPTUNE Match Study

  • Northwell/Cohen's Children's Hospital, New Hyde Park
  • Columbia University Medical Center, New York
Namoota walitti qabaa jira
Umuriin 1 hanga 80 · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT04571658

Nephrotic Syndrome Study Network

  • Cohen Children's Hospital, New Hyde Park
  • New York University Medical Center, New York
  • Bellevue Hospital, New York
  • fi 3 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 80 · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT01209000

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • Cohen Children's Medical Center, New Hyde Park
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 17 · Saalaa hunda · Haaromfame 12-Cam-2026 · NCT05003986

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

  • Cohen Children's Medical Center, New Hyde Park
Namoota walitti qabaa jira
Umuriin 3 hanga 17 · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT05583942

taVNS for FRNS in Children

  • Cohen Children's Medical Center, New Hyde Park
Namoota walitti qabaa jira
Umuriin 3 hanga 17 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT05588063

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.